{"id":566932,"date":"2025-05-12T16:54:38","date_gmt":"2025-05-12T13:54:38","guid":{"rendered":"https:\/\/analyse.optim.biz\/?p=566932"},"modified":"2025-05-12T16:54:38","modified_gmt":"2025-05-12T13:54:38","slug":"un-tratament-american-antiobezitate-mai-eficient-decat-semaglutida-pentru-pacientii-fara-diabet","status":"publish","type":"post","link":"https:\/\/analyse.optim.biz\/?p=566932","title":{"rendered":"Un tratament american antiobezitate, mai eficient dec\u00e2t semaglutida pentru pacien\u021bii f\u0103r\u0103 diabet"},"content":{"rendered":"<div class=\"post-content\">\n<p class=\"p2\"><span class=\"s1\">Laboratorul american Eli Lilly a anun\u021bat luni c\u0103 medicamentul s\u0103u anti-obezitate Mounjaro, bazat pe molecula tirzepatid\u0103, a fost mai eficient dec\u00e2t molecula concurent\u0103 semaglutid\u0103 \u00een cazul adul\u021bilor obezi f\u0103r\u0103 diabet, potrivit <a href=\"https:\/\/sante.lefigaro.fr\/medecine\/anti-obesite-un-traitement-americain-plus-efficace-que-le-semaglutide-pour-les-patients-sans-diabete-20250512\" target=\"_blank\" rel=\"noopener\">Le Figaro<\/a>.<\/span><\/p>\n<div class=\"code-block code-block-15\">\n<p class=\"donate-section\"><a class=\"button\" href=\"https:\/\/www.g4media.ro\/redirectioneaza-35-din-impozitul-pe-venit-pentru-g4media-termenul-limita-pentru-trimiterea-declaratiei-la-anaf-este-25-mai.html\"><strong>Sus\u021bine G4Media. Click <u>AICI<\/u> pentru a redirec\u021biona 3.5% din impozit &#8211; online, gratuit \u0219i simplu.<\/strong><\/a><\/p>\n<h4>Urm\u0103re\u0219te cele mai noi produc\u021bii video G4Media<\/h4>\n<h5>&#8211; articolul continu\u0103 mai jos &#8211;<\/h5>\n<\/div>\n<p class=\"p2\"><span class=\"s1\">Publicate duminic\u0103 \u00een New England Journal of Medicine, rezultatele unui studiu de ultim\u0103 etap\u0103 au ar\u0103tat c\u0103 tratamentul cu tirzepatid\u0103 a fost superior tratamentului cu semaglutid\u0103 \u201e\u00een ceea ce prive\u0219te reducerea greut\u0103\u021bii \u0219i a circumferin\u021bei taliei la s\u0103pt\u0103m\u00e2na 72\u201d, adic\u0103 un an \u0219i 5 luni.<\/span><\/p>\n<p class=\"p2\"><span class=\"s1\">\u00cen cadrul acestui studiu de m\u0103surare a eficacit\u0103\u021bii \u0219i siguran\u021bei tirzepatidei fa\u021b\u0103 de semaglutid\u0103 la adul\u021bii supraponderali sau obezi f\u0103r\u0103 diabet, 751 de participan\u021bi au fost repartiza\u021bi aleatoriu pentru a primi tirzepatid\u0103 sau semaglutid\u0103.<\/span><\/p>\n<p class=\"p2\"><span class=\"s1\">Dup\u0103 72 de s\u0103pt\u0103m\u00e2ni de tratament, pierderea medie \u00een greutate observat\u0103 cu Mounjaro a fost de 20,2%, comparativ cu 13,7% pentru semaglutid\u0103. \u00cen ceea ce prive\u0219te modificarea circumferin\u021bei taliei, reducerea medie a fost de 18,4 cm comparativ cu valoarea ini\u021bial\u0103 p\u00e2n\u0103 \u00een s\u0103pt\u0103m\u00e2na 72 cu tirzepatid\u0103 \u0219i de 13 cm cu semaglutid\u0103. \u201eAcest studiu confirm\u0103 valoarea medicamentelor \u00een managementul pacien\u021bilor obezi\u201d, a declarat Lilly \u00eentr-un comunicat de pres\u0103.<\/span><\/p>\n<p class=\"p2\"><span class=\"s1\">Medicamentul Mounjaro \u0219i concurentul s\u0103u Wegovy de la laboratorul danez Novo Nordisk reprezint\u0103 o clas\u0103 de medicamente care imit\u0103 un hormon intestinal, stimul\u00e2nd secre\u021bia de insulin\u0103 \u0219i oferind o senza\u021bie de sa\u021bietate. <\/span><\/p>\n<\/div>\n<p> Source URL: https:\/\/www.g4media.ro\/un-tratament-american-antiobezitate-mai-eficient-decat-semaglutida-pentru-pacientii-fara-diabet.html<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Laboratorul american Eli Lilly a anun\u021bat luni c\u0103 medicamentul s\u0103u anti-obezitate Mounjaro, bazat pe molecula tirzepatid\u0103, a fost mai eficient dec\u00e2t molecula concurent\u0103 semaglutid\u0103 \u00een cazul adul\u021bilor obezi f\u0103r\u0103 diabet, potrivit Le Figaro. Sus\u021bine G4Media. Click AICI pentru a redirec\u021biona 3.5% din impozit &#8211; online, gratuit \u0219i simplu. Urm\u0103re\u0219te cele mai noi produc\u021bii video G4Media [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":566933,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[24],"class_list":["post-566932","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-politics","tag-g4media"],"_links":{"self":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/566932","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=566932"}],"version-history":[{"count":0,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/566932\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/media\/566933"}],"wp:attachment":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=566932"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=566932"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=566932"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}